Startups
Memo Therapeutics

Memo Therapeutics

https://memo-therapeutics.com

Antibody discovery and human immune repertoire analysis platform.

Summary

Seedtable Score
  • 42
Locations
Company Size
  • 11 to 50 employees
Last Stage Round
  • Series C
Industry

Total funding Amount

$59M

Fundraising History

  • Nov 02 '23 Series C
    $28M
  • Feb 01 '22 Unknown
    $40M
  • Nov 01 '20 Unknown
    $15M
  • May 09 '18 Series A
    $5.5M
  • Jul 22 '15 Series A
    $2.3M

Investors

  • Vesalius Biocapital Partners
    Unknown
  • Adjuvant Capital
    Series C
  • Swisscanto Private Equity
    Series C
  • Pureos Bioventures
    Series C
  • Verve Ventures
    Series A
  • Redalpine
    Series A
  • Zürcher Kantonal Bank
    Series A